Acquired savolitinib resistance in non-small cell lung cancer arises via multiple mechanisms that converge on MET-independent mTOR and MYC activation

Lung cancer is the most common cause of cancer death globally with a significant, unmet need for more efficacious treatments. The receptor tyrosine kinase MET has been implicated as an oncogene in numerous cancer subtypes, including non-small cell lung cancer (NSCLC). Here we explore the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Ryan E., Barry, Evan R., Castriotta, Lillian, Ladd, Brendon, Markovets, Aleksandra, Beran, Garry, Ren, Yongxin, Zhou, Feng, Adam, Ammar, Zinda, Michael, Reimer, Corinne, Qing, Weiguo, Su, Weiguo, Clark, Edwin, D'Cruz, Celina M., Schuller, Alwin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295379/
https://www.ncbi.nlm.nih.gov/pubmed/27472392
http://dx.doi.org/10.18632/oncotarget.10859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295379/
https://www.ncbi.nlm.nih.gov/pubmed/27472392
http://dx.doi.org/10.18632/oncotarget.10859

Ejemplares similares